Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05848115 · ClinicalTrials.gov registry record · NA
BiPAP in Pediatric Moderate to Severe Asthma Randomized Control Trial
A NA study, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT05848115 is a NA study that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 67 participants.
The verdict
NCT05848115, a NA study, was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to study if starting bi-level positive airway pressure (BiPAP), a mask that gives pressure to the lungs, works well for children in the emergency department with moderate to severe asthma attacks. The main questions it aims to answer are: 1. Whether initiation of BiPAP at the same time as continuous beta-agonist therapy (e.g., nebulized albuterol) will decrease how long children with moderate to severe asthma attacks need to receive continuous beta-agonist therapy. 2. Whether early BiPAP changes how the lungs function in children with asthma attacks. 3. Whether children receiving early BiPAP experience more issues or side effects than those children who do not. All children will receive the usual treatment for asthma attacks; if they are still experiencing moderate to severe symptoms after the initial treatment, they will be asked to participate in the study. Participants will then wear a mask while they are receiving the continuous beta-agonist therapy. Some patients will receive BiPAP where pressure is given to the lungs and others will have a sham BiPAP mask where no pressure is given to the lungs. Study participants will wear the mask for 4 hours or until their treatment team feels they are ready to come off of the continuous beta-agonist therapy. Participants will receive more medications and decisions on going home or being admitted to the hospital will be decided as usual by their treatment team. Researchers will compare BiPAP versus Control (Sham BiPAP) groups to see if there is a difference in how long continuous beta-agonist therapy is needed, how the lungs are functioning, and number or type of side effects.
Interventions
- DEVICE Bi-level Positive Airway Pressure
- DEVICE Sham Bi-level Positive Airway Pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2023-06-23 |
| Est. Completion | 2025-07-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05848115
The ClinicalTrials.gov registry entry for NCT05848115 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bi-level Positive Airway Pressure is the first listed.
NCT05848115 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05848115 about?
NCT05848115 is a clinical study titled "BiPAP in Pediatric Moderate to Severe Asthma Randomized Control Trial". The goal of this clinical trial is to study if starting bi-level positive airway pressure (BiPAP), a mask that gives pressure to the lungs, works well for children in the emergency department with moderate to severe asthma attacks. The main questions it aims to answer are: 1. Whether initiation of ...
What is the current status of trial NCT05848115?
This trial is currently terminated. It is a NA study. The enrollment target is 67 participants. The study started on 2023-06-23. Estimated completion is 2025-07-07.
What interventions are being tested in trial NCT05848115?
The interventions under investigation include: Bi-level Positive Airway Pressure (DEVICE), Sham Bi-level Positive Airway Pressure (DEVICE).
Who is sponsoring clinical trial NCT05848115?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.